Massimo Volpe

58.8k total citations · 1 hit paper
844 papers, 21.5k citations indexed

About

Massimo Volpe is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Massimo Volpe has authored 844 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 558 papers in Cardiology and Cardiovascular Medicine, 175 papers in Endocrinology, Diabetes and Metabolism and 120 papers in Surgery. Recurrent topics in Massimo Volpe's work include Blood Pressure and Hypertension Studies (265 papers), Hormonal Regulation and Hypertension (128 papers) and Heart Failure Treatment and Management (93 papers). Massimo Volpe is often cited by papers focused on Blood Pressure and Hypertension Studies (265 papers), Hormonal Regulation and Hypertension (128 papers) and Heart Failure Treatment and Management (93 papers). Massimo Volpe collaborates with scholars based in Italy, United States and Germany. Massimo Volpe's co-authors include Speranza Rubattu, Sebastiano Sciarretta, Giuliano Tocci, Francesco Cosentino, Bruno Trimarco, Junichi Sadoshima, Carmine Savoia, Speranza Rubattu, Thomas F. Lüscher and Francesco Paneni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Massimo Volpe

799 papers receiving 20.9k citations

Hit Papers

Endothelial Dysfunction i... 2022 2026 2023 2024 2022 50 100 150 200

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Massimo Volpe 11.7k 4.6k 3.8k 2.9k 2.7k 844 21.5k
Anna F. Dominiczak 9.8k 0.8× 4.2k 0.9× 3.9k 1.0× 2.9k 1.0× 3.5k 1.3× 358 22.1k
Bruno Trimarco 9.7k 0.8× 4.1k 0.9× 2.5k 0.7× 2.9k 1.0× 2.6k 1.0× 616 17.8k
Dimitris Tousoulis 9.1k 0.8× 3.8k 0.8× 2.2k 0.6× 3.9k 1.3× 3.4k 1.3× 811 20.5k
Aroon D. Hingorani 7.0k 0.6× 3.6k 0.8× 3.3k 0.9× 4.5k 1.5× 2.8k 1.0× 266 26.0k
Rudolf A. de Boer 11.3k 1.0× 5.3k 1.2× 3.2k 0.9× 3.3k 1.1× 2.5k 0.9× 559 22.3k
Arshed A. Quyyumi 14.8k 1.3× 5.0k 1.1× 3.5k 0.9× 5.5k 1.9× 6.0k 2.2× 484 29.7k
Roberto Ferrari 19.9k 1.7× 5.6k 1.2× 2.7k 0.7× 5.5k 1.9× 2.5k 0.9× 769 31.3k
François Cambien 10.0k 0.9× 3.9k 0.9× 7.0k 1.9× 3.2k 1.1× 1.8k 0.7× 229 20.8k
William H. Frishman 10.1k 0.9× 2.8k 0.6× 2.2k 0.6× 4.3k 1.5× 1.8k 0.7× 921 20.6k
Olle Melander 6.2k 0.5× 6.3k 1.4× 3.3k 0.9× 3.9k 1.3× 4.4k 1.6× 578 21.3k

Countries citing papers authored by Massimo Volpe

Since Specialization
Citations

This map shows the geographic impact of Massimo Volpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Volpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Volpe more than expected).

Fields of papers citing papers by Massimo Volpe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Volpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Volpe. The network helps show where Massimo Volpe may publish in the future.

Co-authorship network of co-authors of Massimo Volpe

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Volpe. A scholar is included among the top collaborators of Massimo Volpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Volpe. Massimo Volpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tocci, Giuliano, et al.. (2024). Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall. International Journal of Molecular Sciences. 25(5). 2502–2502. 5 indexed citations
2.
Carresi, Cristina, Rocco Mollace, Roberta Macrì, et al.. (2024). The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension. Frontiers in Cardiovascular Medicine. 11. 1345218–1345218. 18 indexed citations
3.
Liuzzo, Giovanna & Massimo Volpe. (2024). Weekly journal scan: every breath you take, air pollution impacts your cardiovascular health. European Heart Journal. 45(24). 2116–2118. 1 indexed citations
4.
Volpe, Massimo, Claudio Borghi, Matteo Cameli, et al.. (2023). Otto motivi per i quali i cardiologi non dovrebbero trascurare il problema “obesità”. Expert opinion per la pratica clinica. Giornale italiano di cardiologia. 24(9). 677–691. 2 indexed citations
6.
Volpe, Massimo & Allegra Battistoni. (2023). What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season?. European Heart Journal Supplements. 25(Supplement_A). A1–A4. 2 indexed citations
7.
Arcari, Luca, Luca Rosario Limite, Camillo Autore, Massimo Volpe, & Beatrice Musumeci. (2018). Un singolare caso di sindrome takotsubo secondaria. Giornale italiano di cardiologia. 19(4). 239–241. 1 indexed citations
8.
Poscia, Andrea, Jovana Stojanovic, Franco Scaldaferri, et al.. (2017). Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients. BioMed Research International. 2017. 1–9. 4 indexed citations
9.
Seravalle, Gino, M. Colombo, Massimo Volpe, et al.. (2014). Long-Term Sympathoinhibitory Effects of Surgically Induced Weight Loss in Severe Obese Patients. Hypertension. 64(2). 431–437. 61 indexed citations
10.
Volpe, Massimo, et al.. (2012). La politerapia in prevenzione cardiovascolare: problemi aperti. Giornale italiano di cardiologia. 13(7). 503–10. 4 indexed citations
13.
Volpe, Massimo. (2012). Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan. Expert Review of Cardiovascular Therapy. 10(8). 1061–1072. 8 indexed citations
14.
Malacco, Ettore, Stefano Omboni, Massimo Volpe, A. Auteri, & Alberto Zanchetti. (2012). ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY. SHILAP Revista de lepidopterología. 13 indexed citations
15.
Savarese, Gianluigi, Francesca Musella, Massimo Volpe, Francesco Paneni, & Pasquale Perrone Filardi. (2012). Abstract 9593: Effects of Atorvastatin and Rosuvastatin on Renal Function: A Meta-analysis. Circulation. 126(suppl_21). 1 indexed citations
16.
Palano, Francesca, Francesco Paneni, Sebastiano Sciarretta, Giuliano Tocci, & Massimo Volpe. (2011). Attuali concetti sullo sviluppo dell’insufficienza cardiaca nell’ipertensione. Recenti Progressi in Medicina. 102(12). 461–7. 11 indexed citations
17.
Grassı, Guıdo, Fosca Quarti‐Trevano, Gino Seravalle, et al.. (2011). Early Sympathetic Activation in the Initial Clinical Stages of Chronic Renal Failure. Hypertension. 57(4). 846–851. 243 indexed citations
18.
Volpe, Massimo & Giuliano Tocci. (2007). Therapeutic implications of recent megatrials in hypertension: in favor of new drugs. Journal of Nephrology. 20(S12). S12–S18. 6 indexed citations
19.
Savoia, Carmine, Rhian M. Touyz, Massimo Volpe, & Ernesto L. Schiffrin. (2006). Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients. Hypertension. 49(2). 341–346. 103 indexed citations
20.
Sturani, A, et al.. (2002). Long-term persistence with anti hypertensive drugs in new patients. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026